NCT00164242View on ClinicalTrials.gov

Treatment of Tardive Dyskinesia With Galantamine

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

October 31, 2004

Conditions
Tardive Dyskinesia
Interventions
DRUG

Galantamine

Trial Locations (1)

19104

Philadelphia VA Medical Center, Philadelphia

All Listed Sponsors
collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Caroff, Stanley N., M.D.

INDIV

NCT00164242 - Treatment of Tardive Dyskinesia With Galantamine | Biotech Hunter | Biotech Hunter